NASDAQ: WHWK Whitehawk Therapeutics, Inc. 10-K

Whitehawk divests FYARRO, advances two ADC candidates into Phase 1 trials

Filed March 12, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 28, 2025 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade WHWK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.